Screening Standards Evolve When Technology Makes the Old Approach Obsolete

Medical standards don’t change easily. There’s inertia built into clinical practice by training, infrastructure investment, reimbursement frameworks, and institutional habit. When a standard of care has been in place for decades, displacing it — even with demonstrably better technology — takes time, evidence, and a broad shift in clinical and patient awareness.

Breast cancer screening is experiencing exactly that kind of shift right now.

Mammography has been the cornerstone of breast cancer screening in the United States since the 1970s. The evidence base for its effectiveness is substantial. The infrastructure supporting it is vast. And yet the clinical community has increasingly acknowledged its limitations — particularly for the large portion of the population with dense breast tissue, and particularly in the context of what newer imaging technologies have demonstrated they can deliver.

The koning vera breast ct system represents one of the most significant developments in that shift — a purpose-built dedicated breast CT platform that addresses the structural limitations of projection-based mammography at a fundamental level.

The Problem With Projecting a 3D Structure Into 2D

This is worth articulating clearly, because it’s the core issue that dedicated breast CT addresses.

The human breast is a three-dimensional structure. It has depth, volume, and complex internal architecture — a mix of glandular tissue, fibrous stroma, ducts, blood vessels, and fatty tissue, all interwoven in ways that vary significantly from person to person. A potential cancer or other concerning finding exists somewhere in that three-dimensional volume.

Standard mammography takes that three-dimensional structure and projects it onto a two-dimensional image. The depth information is collapsed. Structures that exist at different depths in the breast are superimposed on each other in the projection image. This creates visual complexity that the interpreting radiologist has to parse — often making judgment calls about whether an area of interest represents a real finding or an artifact of overlapping tissue.

Tomosynthesis improved on this by acquiring multiple projection images and reconstructing them into a limited pseudo-3D dataset. But it’s still a projection-based approach, and it still uses compression.

Dedicated breast CT eliminates the projection constraint entirely. The imaging is genuinely volumetric — the radiologist is reviewing a complete three-dimensional dataset of the breast, with full depth information preserved. There’s no tissue superimposition. The architectural relationships within the breast are visible as they actually exist.

The Radiologist’s Perspective

It’s worth stepping into the radiologist’s experience for a moment, because understanding what changes for the interpreting physician helps clarify why the technology matters clinically.

Reading a mammogram — particularly in a dense-breast case — requires significant interpretive skill and experience. The radiologist is looking for subtle density changes, asymmetries, or masses against a background that may itself be quite dense and visually complex. The finding, if present, may be small. The visual environment may be noisy. And the consequences of missing something are profound.

Dedicated breast CT changes the interpretive environment substantially. The radiologist is no longer looking at a flat projection with all its inherent ambiguity. They’re scrolling through a three-dimensional volume, reviewing tissue layer by layer, with the ability to look at any plane and to correlate findings across multiple orientations.

Findings that would require significant interpretive inference on a mammogram become clearly visible in the volumetric dataset. The confidence threshold for characterizing a finding — or ruling one out — is meaningfully different. That difference translates into fewer missed findings and fewer false alarms.

What Patients Experience

The patient experience of dedicated breast CT is one of its most immediately compelling aspects, particularly for women who have found standard mammography difficult.

breast ct scan using the Koning Vera system is performed with the patient lying comfortably face-down on a specially designed table. The breast is positioned through an opening so it hangs naturally — no compression, no plates, no need to hold a position through discomfort. The acquisition takes a matter of seconds.

For many women, the contrast with standard mammography is striking. The absence of compression — the defining characteristic of No compression breast imaging removes both the physical discomfort and the anticipatory anxiety that many women associate with mammography. The procedure is fast, non-threatening, and notably more comfortable.

This matters for public health reasons that go beyond individual comfort. Screening compliance is one of the most important variables in breast cancer outcomes at the population level. When screening is less aversive, more women do it consistently. Consistent screening means earlier detection. Earlier detection means better outcomes. The patient experience of a screening technology is therefore not a secondary concern — it’s a clinical variable with real downstream effects.

The Dose Question

Any conversation about CT imaging appropriately includes a discussion of radiation dose. CT scanning in other applications — chest, abdomen, head — uses higher radiation doses than conventional X-ray imaging. So the natural question when encountering dedicated breast CT is: what’s the dose?

The Koning Vera system was engineered specifically for breast imaging, with dose optimization as a primary design consideration. The system’s geometry, detector technology, and acquisition parameters are all optimized for breast tissue specifically — not adapted from a general-purpose CT platform. The result is a radiation dose that is comparable to standard mammographic screening and, in many acquisition protocols, lower than what would be associated with standard or tomosynthesis mammography.

This is a clinically important point. The imaging benefits of volumetric breast CT — the detection improvements, the density clarity, the reduction in false positives and false negatives — come without a meaningful increase in radiation exposure compared to the screening approach they’re improving upon.

How the Technology Is Being Deployed in the US

The koning vera breast ct system has received FDA clearance and is being deployed at imaging centers across the United States. The adoption curve is at an early stage — this is not yet a technology available at every mammography facility — but the trajectory is clear.

Imaging centers that have adopted the technology are typically offering it initially for specific clinical indications: dense breast tissue, diagnostic workup after an abnormal mammogram finding, surveillance imaging for women with elevated lifetime risk, or as an alternative to standard screening for women who have experienced difficulty with mammography.

As the evidence base continues to build, as reimbursement frameworks evolve, and as awareness among patients and referring physicians grows, the availability of dedicated breast CT is expected to expand. Women who are proactively asking about it are positioning themselves to access the technology as it becomes available in their area.

The Longer Arc of Breast Imaging

It would be historically shortsighted to assume that the breast imaging landscape of today is the landscape of ten years from now. Technology in medical imaging has a track record of meaningful evolution — from plain-film mammography to digital mammography, from digital mammography to tomosynthesis, and now into the volumetric era of dedicated breast CT.

Each transition has expanded detection capability, improved patient experience, or both. The transition currently underway — toward true volumetric imaging of the breast — represents the most significant structural change in breast imaging technology in decades. Understanding it, and advocating for access to it, is part of being an informed participant in your own healthcare.

Ask the Right Questions at Your Next Screening

If you’re scheduled for breast cancer screening, or if you’re due for screening and haven’t yet scheduled it, this is a good moment to ask your imaging center or your primary care provider about dedicated breast CT options. Ask whether they offer it. Ask whether your breast density or clinical history makes it a particularly good fit. Ask about availability and what the process would look like.